Introduction
Granulopoiesis is a complex process by which primitive blood precursors differentiate into fully differentiated, functionally active granulocytes. Studies on the production of neutrophilic granulocytes and other myeloid cells have provided important paradigms for understanding differentiation. In particular, this work has revealed the intricate and often essential roles played by various transcription factors -both those specific to the granulocytic lineage, as well as more widely expressed molecules -in the control of differentiation. Such transcription factors can act both positively and negatively to regulate the expression of a wide range of important genes, including growth factors and their receptors, other transcription factors, as well as various molecules important for the function of the mature cells. In addition, the activity of several transcription factors is controlled by external stimuli, such as cytokines. Finally, there is a complex interplay between all of these factors -synergistic and antagonistic -which allows for the exquisite control of granulocytic cell production that is observed.
Several genes expressed specifically by immature granulocytic cells have been extensively studied. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] From this work, the transcription factors C/EBP␣, PU.1, CBF and c-Myb have emerged as key regulators of gene expression during early granulopoiesis and will be a major focus of this review (Table 1) . Furthermore, other studies have implicated several additional transcription factors in the control of granulopoiesis. For example, C/EBP⑀ is expressed predominantly in latestage granulocytic differentiation and contributes to the expression of a number of key genes, 15, 16 family members are restricted in their expression, within hematopoiesis, to myeloid cells, [17] [18] [19] while the WT-1 gene is expressed in immature hematopoietic cells and in a subset of acute myeloid leukemias. 20, 21 Finally, a number of more ubiquitous transcription factors are known to perform important roles in granulopoiesis in responses to external stimuli: for example, Stat proteins, Myc, and Mad in response to cytokines and the retinoic acid receptor (RAR) in response to retinoic acid.
Transcription factors active during granulopoiesis

C/EBPs
C/EBP␣ (Figure 1 ) is the founding member of a subset of bZIP transcription factors which include C/EBP␤, C/EBP␥, C/EBP␦, C/EBP⑀ and CHOP. [22] [23] [24] [25] [26] C/EBPs form homo-or hetero-dimers via their leucine zipper domains and bind a common DNA element, 5′-T(T/G)NNGNAA(T/G)-3′, via their basic regions. 26 C/EBP␣ is a transcriptional activator 27 and has two transactivating domains N-terminal to the bZIP segment. 28 CCAAT/enhancer binding protein ␣ (C/EBP␣) is expressed in multiple cell types, including adipocytes, hepatocytes and enterocytes. 29, 30 Within the hematopoietic compartment, C/EBP␣ expression is restricted to the neutrophil, monocyte and eosinophil lineages, [31] [32] [33] being detected in human CD34 +
CD33
+ myeloid progenitor cells, but not in nonmyeloid CD34 +
− cells. 33 C/EBP␣ is the predominant gelshift species observed in an immature myeloid cell line, 7 while its levels decrease during the granulocyte colony-stimulating factor (G-CSF)-mediated granulocytic differentiation of 32D cl3 cells. 31 Inducible expression of C/EBP␣ in the U937 and HL-60 human leukemia cell lines led to the emergence of neutrophilic cells after 2 weeks, with increased expression of the mRNAs for G-CSF receptor (G-CSF-R), lactoferrin, and neutrophil collagenase. 33 Similarly, introduction of C/EBP␣ into multipotent MEP cells led to induction of both myeloid and eosinophil markers. 34 C/EBP␣ linked to the ligand-binding domain of the estradiol receptor (ER), was also introduced into the 32D cl3 cell line. 35 When exposed to estradiol, these cells underwent neutrophilic differentiation over a 4-day period, even in the presence of IL-3. MPO RNA induction was detected by 8 h, and G-CSF-R and lactoferrin RNA induction were detected at later times. Consistent with these studies, C/EBP␣-null mice lack neutrophils and eosinophils, but retain monocytes and lymphocytes. 36 Fetal liver cells from these mice lack detectable G-CSF-R mRNA but retain normal levels of GM-CSF-R and M-CSF-R mRNAs, and hematopoietic colonies are obtained from these cells in response to GM-CSF and M-CSF, but not G-CSF. Colonies grown in GM-CSF contain immature myeloid cells, but not mature neutrophils. 36 Expression of early granulocytic or monocytic markers in these cells has not been evaluated. These data indicate that C/EBP␣-deficient cells can commit and mature along the monocytic lineage but cannot fully mature along the neutrophilic lineage. In using the phenotypes of C/EBP␣-knockout mice to develop a model of the hierarchical regulation of hematopoiesis, one must keep in mind the possibility that other C/EBP family members could compensate for the loss of C/EBP␣. Precedent for such compensation exists in GATA-1-knockout mice, in which GATA-2 levels become elevated, enabling further differentiation along the erythroid and megakaryocytic lineages than would perhaps otherwise occur. 37, 38 In contrast to C/EBP␣, C/EBP␤ levels increase during the differentiation of 32D cells. 31 However, C/EBP␤-null mice have reduced B cell numbers and defects in macrophage activation, but otherwise normal myelopoiesis. [39] [40] [41] The ability of C/EBP␤, but not C/EBP␣, to cooperate with Sp1 in hepatocytes suggests that a similar collaboration may occur in granulocytic cells. 42 C/EBP␥ is a ubiquitous protein which lacks a transactivation domain and can dimerise with other C/EBPs and interfere with their activities. 43, 44 C/EBP⑀ is expressed in Tlineage cells and predominantly in late-stage granulocytes. 15, 45, 46 C/EBP⑀ null mice show defects in neutrophil function, suggesting that C/EBP⑀ controls the expression of a number of key genes. 16 This is consistent with a recent study showing that neutrophil-specific granule deficiency results from a loss of function in C/EBP⑀. 47 CHOP contains a defective basic region but has an intact leucine zipper, 48 and is only expressed in 32D cl3 cells in response to cytotoxic stress, where it dominantly inhibits C/EBP activities and reduces G-CSF responsiveness, perhaps via interference with G-CSF receptor expression. 49 
PU.1
PU.1 ( Figure 1 ) is a member of the Ets family of transcription factors, possessing a glutamine-rich trans-activating domain at its N-terminus, and a C-terminal DNA binding domain which binds to a consensus site 5′-AAAG(A/C/G)GGAAG-3′. 50, 51 PU.1 is phosphorylated on multiple residues, including serines 41, 45, and 132 and/or 133, and 148.
52 Both ERK1, a MAP kinase, and JNK1, a Jun kinase, can phosphorylate PU.1, 53 with phosphorylation of serines 41 and 45 possibly regulating PU.1 activities in myeloid cells. 54 Phosphorylation of serine 148 in PU.1 mediates its binding to Pip, an essential cofactor in B cells. 55 However, the role of serine phosphorylation at this site in myeloid cells is controversial. Although phosphorylation of serine 148 was required for LPS-mediated gene activation in macrophages, mutation of this residue did not alter the ability of PU.1 to stimulate macrophage proliferation. 54, 56 Both the glutamine-rich and an acidic domain of PU.1 show transcriptional activity in HeLa cells. 57 However, these domains have only weak activity, suggesting that PU.1 needs to cooperate with additional factors to effectively contribute to gene activation. Integrity of both the C-terminal PU.1 DNA-binding domain and its N-terminal glutamine-rich trans-activating domain, but not the acidic domain, were required for PU.1 to rescue myelopoiesis in PU.1−/− ES cells. 58 PU.1 is expressed in granulocytic, monocytic and B lymphoid cells. 50, 59 PU.1 levels increase during the granulocytic differentiation of CD34
+ bone marrow cells as well as the FDCPmix and 32D cl3 cell lines. 9, [59] [60] [61] Introduction of a PU.1-ER fusion protein into MEP cells, and subsequent treatment with estradiol to activate PU.1, resulted in increased expression of two myeloid markers and decreased expression of GATA-1 and two progenitor markers. 62 Similarly, activation of a PU.1-ER(T) fusion by 4-hydroxytamoxifen (4HT) in 32D cl3 cells led to increased MPO RNA expression although, in contrast to C/EBP␣, terminal granulocytic maturation was not observed. 35 These results are consistent with the phenotype of 32D cl3 63 The two reported PU.1 deficient murine lines have in common a lack of monocytes and B lymphoid cells and a greatly impaired production of neutrophils. 64, 65 Those neutrophils produced do not express some markers of terminal differentiation. 66 The hematopoietic progenitors from these mice express very low levels of the receptors for M-CSF, G-CSF, and GM-CSF, and do not proliferate in response to the corresponding cytokines alone. 67, 68 However, PU.1-deficient progenitors can produce immature myeloid cells in response to the combination of IL-3 and G-CSF, 67 although introduction of the G-CSF-R or M-CSF-R into PU.1-deficient marrow cells did not enable terminal neutrophilic or monocytic differentiation in response to the corresponding factors, while introduction of exogenous PU.1 did. 69 Hematopoietic colonies grown from PU.1 knockout mice in the presence of IL-3, SCF, GM-CSF and M-CSF contain cells with markers of immature monocytes. 70 Thus, PU.1-deficient cells can commit to the neutrophilic and monocytic lineages, but cannot fully mature along these lineages. In contrast, yolk sac-derived phagocytes were recently shown to be distinct from embryonic and adult phagocytes and to be capable of developing in PU.1-null mice. 71 
Core binding factor (CBF)
CBF is a family of heterodimeric proteins containing one of three CBF␣ subunits bound to a common CBF␤ subunit [72] [73] [74] [75] [76] [77] [78] ( Figure 1 ). The CBF␣ subunits contain a DNA-binding domain (DBD) homologous to that of the Drosophila Runt protein, 79 which mediates both DNA-binding and heterodimerization with CBF␤. 76, 80 The DNA consensus binding site for CBF is 5′-PuACCPuCA-3′. 72, 80, 81 Interestingly, the Runt domain can bind ATP, although the significance of this binding is not known.
82,83 CBF␤ does not bind DNA itself, but increases the binding affinity of the CBF␣ subunits. 75, 77 CBF alone has only a weak trans-activation domain. 2, 84 However, CBF potentiates trans-activation by C/EBP␣, c-Myb, PU.1 and Ets-1, either via cooperative DNA-binding or via interactions with co-activators. 10, [85] [86] [87] [88] [89] [90] [91] Recently, a novel mechanism of cooperativity was identified -binding of Ets-1 to CBF␣2 disrupts the interaction of the CBF␣2 C-terminus with the Runt domain, thereby stimulating DNA binding. 92 Drosophila Runt can also repress transcription via interaction of a C-terminal motif, VWRPY, with Groucho. 93 CBF␣ subunits similarly interact with TLE, a mammalian Groucho homologue. 94, 95 Repression by CBF␣2 may also be mediated by the mSin3 or N-CoR co-repressors. 96, 97 CBF␣2 can be phosphorylated by ERK at serines 276 and 293 and is phosphorylated in hematopoietic cells, although the role of CBF phosphorylation is uncertain. [98] [99] [100] In addition, the CBF␣ subunits each contain a 30 amino acid segment which mediates strong affinity for the nuclear matrix. 101 However, neither the nuclear matrix binding partner nor the significance of this interaction is known.
Of the three CBF␣ subunits, only CBF␣2 (also called AML1) is expressed specifically in hematopoietic cells, being largely restricted to myeloid and lymphoid cells in adult mammals. 99, 100, 102 Expression in hematopoietic stem cells has also been demonstrated using mice carrying the lacZ gene embedded in the CBF␣2 locus. 103 Consistent with their expression in pluripotent marrow cells, mice lacking CBF␣2 or CBF␤ lack all lineages of definitive hematopoiesis. [104] [105] [106] [107] [108] Lack of hematoLeukemia poiesis might result from the inability of primitive mesodermal cells to commit to hematopoiesis -alternatively, inhibition of cell proliferation due to loss of CBF activity, as observed in hematopoietic cell lines, may explain the phenotypes of these knockout mice.
109,110
c-Myb
The transcription factor c-Myb contains three imperfect 50-52 amino acid repeats at its N-terminus, R1, R2 and R3 ( Figure 1 ). The R2 and R3 domains mediate DNA contact with the consensus site 5′-(C/T)AAC(G/T)G-3′, while R1 stabilizes this interaction. [111] [112] [113] [114] These domains contain evolutionarily conserved tryptophans every 18-19 residues which help form the hydrophobic core of the helix-turn-helix DNA-binding structure. 115 Two mammalian c-Myb homologues, A-Myb and B-Myb, have been identified. These three mammalian Myb family members are highly homologous in their DNA-binding domains, as well as in several other regions, with each able to bind the c-Myb consensus site. 116, 117 c-Myb contains a centrally located trans-activating domain. [118] [119] [120] The C-terminal region of c-Myb contains an evolutionarily conserved EVES motif which acts as a negative regulatory domain by interacting with the c-Myb N-terminal DNA-binding domain. 121 Interestingly, a co-activator protein, p100, contains a similar EVES motif and can also interact with the c-Myb DNA-binding domain. 121 Whether p100 activates or represses c-Myb activity in vivo by this interaction remains to be determined. Phosphorylation of serines 11 and 12 of c-Myb, by casein kinase II in vitro or by unidentified kinases in vivo, inhibits cMyb DNA-binding. 122 Phosphorylation of a serine just downstream of the EVES motif reduces c-Myb's trans-activation potency. 123 Perhaps this phosphorylation stabilizes the interaction of the EVES domain with the c-Myb N-terminus. In addition to the EVES motif, the negative regulatory domain of c-Myb contains a leucine zipper. Mutations in this motif increase c-Myb DNA affinity, and phosphorylation of serines 11 and 12 prevents leucine zipper-mediated inhibition of DNA binding. 124, 125 A protein, termed p160, has been identified which interacts with c-Myb via its leucine zipper. 126 Perhaps this protein also interacts with the c-Myb N-terminus and inhibits DNA-binding if serines 11 and 12 are not phosphorylated.
c-Myb is predominantly expressed in immature lymphoid, erythroid, and myeloid cells and has also been detected in cells of the intestinal crypt and hair follicle in adult mice. [127] [128] [129] [130] Consistent with its expression pattern, c-Myb knockout mice lack all hematopoietic lineages except the megakaryocytic branch. 131 In addition, ectopic expression of c-Myb in 32D cl3 cells allowed G-CSF induction of early differentiation markers, such as MPO. However, terminal differentiation, with associated growth arrest and lactoferrin induction, was inhibited. 132 These results are in agreement with the idea that c-Myb stimulates cell proliferation and that cell cycle arrest is required for the terminal phases of granulopoiesis. Indeed cMyb has been implicated in the regulation of the G1/S cell cycle transition, and Drosophila Myb has been shown to be required for the G2/M transition. [133] [134] [135] A-Myb is expressed in the developing CNS, in the adult testis, and in a subset of germinal center B lymphoid cells, 117, 136, 137 while B-Myb is expressed ubiquitously in proliferating cells and may help regulate cell cycle progression. 138, 139 The severe hematopoietic phenotype present in c-Myb-null mice indicates that neither A-Myb nor B-Myb can compensate for the loss of 
Homeobox (Hox) proteins
Hox proteins possess a specific helix-turn-helix DNA-binding motif, termed the homeo domain. 140 Multiple members of this protein family are expressed in hematopoietic cells, with a number of them specifically implicated in granulopoiesis. HoxB4 is expressed in the most early hematopoietic progenitors. Overexpression of this protein leads to a selective expansion of these primitive progenitors without affecting their differentiation. 141 Both HoxA9 and HoxA10 are highly expressed in human CD34
+ cells, but are down-regulated during myeloid development. 19, 142 Hematopoietic analysis of mice with a targeted disruption of the hoxA9 gene revealed reduced granulocytes (as well as lymphocytes), and a decreased responsiveness to G-CSF, suggesting that HoxA9 has an important function in committed progenitor cells. 142 In contrast, hoxA10 knockouts showed a two-fold increase in circulating neutrophils (and monocytes). 143 In addition, overexpression of HoxA10 in mouse bone marrow perturbed myeloid differentiation and led to acute myeloid leukemia.
141
HoxA5 is also expressed during early myelopoiesis -inhibition of HoxA5 expression with antisense oligonucleotides inhibited granulocytic and monocytic hematopoiesis. 144 Other homeobox genes, such as Hlx and HoxB7, are expressed in mature granulocytic cells. 145, 146 Retroviral expression of Hlx enhanced myeloid maturation, 145 while overexpression of HoxB7 inhibited granulocytic differentiation of HL-60 cells. 146 Thus, specific Hox family members appear to act as important regulators at distinct stages of lineage commitment and granulopoiesis.
Wilms' tumor suppressor protein (WT-1)
The WT1 protein contains four zinc fingers at its carboxyl terminus and a transcriptional regulatory domain. 147 Within the coding region of this transcriptional regulatory domain, exon 5 is alternatively spliced, 148 while RNA editing occurs within exon 6 which can modify its activity. 149 A second alternative splicing event inserts or removes a three amino acid sequence (KTS) from the 5′ end of exon 10. 148 The KTS insert disrupts the spacing between zinc fingers 3 and 4 which profoundly affects DNA binding. Isoforms lacking the KTS insert bind to a GC-rich motif that is very similar to the known Egr-1 binding site, suggesting that WT1 possibly modulates the ability of Egr-1 to induce monocytic differentiation. 150 Other high-affinity binding sites for WT1 have also been identified. 151 Although isoforms containing the KTS insert bind DNA, a consensus binding site has not been established. 152 WT1 can mediate both transcriptional activation and repression. [153] [154] [155] WT1 isoforms with the KTS insert interact with components of the RNA splicing machinery in vitro, 156, 157 and in living cells they are localized to nuclear coiled bodies, which are hypothesized to play a role in the assembly and maturation of splicing complexes. 156 
WT1 is expressed in CD34
+ bone marrow cells 20, 158 -treatment of these cells with stem cell factor and G-CSF downregulates its expression. 159 WT1 expression is similarly reduced in HL-60 and K562 cells induced to differentiate. 160, 161 In M1 cells, WT1 expression is induced by treatment with leukemia inhibitory factor. Exogenous expression of isoforms containing the KTS insert induces spontaneous monocytic differentiation of these cells, while expression of isoforms lacking the KTS insert induces G1 arrest and apoptosis. 162 In contrast, enforced expression of the isoform containing both exon 5 and the KTS insert in 32D cl3 cells blocks G-CSF-mediated granulocytic differentiation and promotes survival in the absence of IL-3, 163 while expression of the variant lacking exon 5 and the KTS insert accelerates G-CSF-induced differentiation (DML, ADF and S Sukumar, unpublished). Perhaps the opposing effects on monocytic and neutrophilic differentiation of WT1 isoforms with or without the KTS insert reflects the action of WT1 during normal hematopoiesis.
Several target genes of WT1 have been identified that may be important in the control of renal or gonadal differentiation, such as the EGF receptor, the insulin-like growth factor receptor, and Dax-1. [164] [165] [166] We recently found the WT1 isoform lacking both exon 5 and the KTS insert binds to sites within the cyclin E promoter, down-regulates its transcriptional activity, and reduces cyclin E protein expression in 32D cl3 cells (DML ADF and S Sukumar, unpublished), which possibly contributes to differentiation induction. WT1 also upregulates the anti-apoptotic gene bcl-2, 167 which is of considerable interest in view of the finding that overexpression of WT1 is associated with a poor outcome in patients with acute leukemia. 21 Finally, repression of the human RAR␣ gene via a GCrich sequence may be relevant to regulation of hematopoiesis by WT1. 168 
Retinoblastoma protein (Rb)
When hypophosphorylated, Rb cooperates with E2F family members to inhibit expression of genes required for S-phase entry. 169 Rb knockout mice show defective hematopoiesis with an increased number of immature erythrocytes entry. 170 Rb expression is down-modulated in granulocytic differentiation, while it is up-regulated during erythroid and monocytic differentiation. 171, 172 Suppression of Rb expression in human marrow myeloid progenitors using anti-sense oligonucleotides inhibited monocytic in favor of granulocytic differentiation without effecting their colony-forming ability, 172 suggesting that Rb functions as a switch between the monocytic and granulocytic lineages. The ability of Rb to interact with C/EBP␤ and PU.1 may be of relevance to this observation. 173, 174 When complexed to these factors, hypophosphorylated Rb may potentiate their ability to contribute to both monocytic and neutrophilic differentiation, with one of these complexes being in fact essential for monopoiesis.
Retinoic acid receptor (RAR)
Retinoids have long been known to participate in myeloid differentiation, with addition of retinoids observed to stimulate granulopoiesis, 175, 176 while lack of retinoids (for example, vitamin A deficiency) has been associated with defective hematopoiesis. 177 In addition, retinoic acid could induce granulocytic differentiation of the HL60 myeloid cell line and of primary cells from acute promyelocytic leukemia (APL) patients. 178, 179 Retinoid activity is mediated via two different families of nuclear receptors: the retinoic acid receptors (RAR␣, RAR␤, RAR␥) which bind both all-trans retinoic acid (ATRA) and 9-cis retinoic acid, 180 and the retinoid X receptors
977
(RXR␣, RXR␤, RXR␥) which only bind 9-cis retinoic acid.
181
Of the three RARs, RAR␣ is preferentially expressed in myeloid cells.
182
RAR␣ binds to specific DNA sequences called retinoic acid response elements (RAREs), which consist of a direct repeat of the sequence (A/G)G(G/T)TCA separated by 2-5 nucleotides. 183, 184 High-affinity binding of RARs is achieved via heterodimerization with a member of the RXR family, and is regulated by the presence or absence of ligand. In the absence of ATRA, RAR␣ is associated with the co-repressor proteins N-CoR and SMRT. This leads to recruitment of transcriptional repressor proteins, such as mSin3, as well as histone deacetylases (HD). 185, 186 Subsequent deacetylation of histone proteins results in nucleosome assembly and transcriptional repression, as the chromatin becomes inaccessible to both transcriptional activators and the basal transcription machinery. 187, 188 In the presence of ligand, the corepressor and HD proteins are released and replaced by coactivator proteins, such as TIF1␣, SRC-1 and ACTR. [189] [190] [191] This leads to acetylation of the histone proteins -either directly through co-activators like SRC-1 and ACTR, or indirectly through recruitment of CBP and p/CAF -resulting in transactivation of gene expression. 191, 192 While treatment of cells with ATRA ultimately induces many genes, including cytokine receptors, enzymes and adhesion molecules, relatively few appear to be direct target genes. Indeed, many of the direct targets are themselves transcription factors, including C/EBP⑀, Hox proteins and Stat1. [193] [194] [195] However, in myeloid cells RAR␣ induces the expression of the p21 waf1/cip1 cyclin-dependent kinase inhibitor through interaction with an imperfect RARE in the p21 promoter, 196 as well as E3, a hematopoietic specific factor of unknown function. 197 Expression of a dominant-negative RAR␣ in a multipotent cell line changed the developmental fate of these cells from the granulocytic/monocytic to the mast cell lineage. 198 GM-CSF-induced differentiation of these cells was blocked at the promyelocyte stage. 199 In addition, while no major perturbations in hematopoiesis were observed in RAR␣ knockout mice, 200 RAR␣ −/− ES cells fail to mature into granulocytes. 201 More recent studies with purified cell subsets have shown that ATRA delays the maturation of primitive hematopoietic precursors, while enhancing the terminal differentiation of committed granulocytic/monocytic precursor cells, 202 which might partially explain this anomaly.
STATs
Stats are latent cytoplasmic transcription factors that are recruited to activated cell-surface receptors, where they become tyrosine phosphorylated. Subsequently, these Stats homo-or hetero-dimerise, translocate to the nucleus, and effect gene expression by binding to specific promoter elements. Seven Stat proteins have been identified in mammalian cells, with additional isoforms of several Stats also identified. 203 Individual Stats bind to similar DNA response elements, variants of the sequence TTN 4-6 AA. [204] [205] [206] However, there is a considerable degree of specificity, such that different genes are targeted by different Stat complexes. 207 Stat proteins interact with a number of other nuclear factors and co-activators, including CBP, Nmi, the glucocorticoid receptor, c-Jun and MCM5, 203, [208] [209] [210] which increases the scope of transcriptional responses in which Stats can participate. While tyrosine phosphorylation is critical for Stat activation, serine phosLeukemia phorylation probably also affects their activity. [211] [212] [213] [214] Indeed, Ser727 of Stat1␣ has been shown to be directly involved in the recruitment of MCM5 as part of interferon ␥-induced transcriptional activation. 209 Several important genes are activated by Stat proteins, including p21 WAF1/Cip1 , c-fos, cis and cyclin D1. [215] [216] [217] [218] Cytokines important for granulopoiesis are known to activate Stats. GM-CSF and IL-3 activate Stat5, 219 while G-CSF activates Stat3, Stat5 and some Stat1. [220] [221] [222] [223] Targeted disruption of the Stat3 gene gave early embryonic lethality, 224 while mice with both forms of Stat5 knocked out exhibited multiple defects, with responses to IL-3, GM-CSF and G-CSF affected. 225 Expression of dominant-negative Stats, or specific receptor mutants, has provided further evidence of the essential role of Stats in mediating responses from cytokine receptors during granulopoiesis. These studies have shown, for example, that Stat3 activation plays a key role in the differentiation responses to G-CSF, [226] [227] [228] while Stat5 appears important for proliferative responses to IL-3, GM-CSF, and G-CSF.
219,229,230
c-Myc/Mad
The c-myc gene encodes a basic helix-loop-helix/leucine zipper-containing transcriptional activator protein c-Myc. This dimerises with another small basic helix-loop-helix protein Max in order to bind DNA and transactivate gene expression from E-box (CACGTG) sites. 231, 232 Myc expression is rapidly induced following cytokine stimulation of responsive cells. 233, 234 Many known c-Myc target genes are involved in cell cycle progression or protein translation. 235 Consistent with this, the c-myc gene is known to have oncogenic potential and high expression of c-myc is associated with proliferation and a block in differentiation. 236, 237 Both the oncogenic activity and the cell proliferation promoting activity is mediated by the Myc-Max heterodimeric complexes. 238 How c-Myc controls the cell cycle is not completely understood. Apart from the transcriptional control of target genes directly involved in DNA synthesis or protein translation (such as ornithine decarboxylase), two more direct cell cycle modifying effects of c-Myc have been suggested: (1) via upregulation of cdc25A and thereby activation of cyclin-dependent kinases, and (2) via sequestration of the general G1 cyclin-dependent kinase inhibitor p27
Kip1 from G1 cyclin/CDK complexes.
239,240
The latter mechanism would be mediated by yet unidentified c-Myc target gene(s), the protein product of which can probably directly bind to p27. Of note, evidence suggesting that cdk4 can sequester p27 was recently presented. 241 Studies in a c-Myc knockout cell line further establish a role for c-Myc in the control of cell proliferation. In these cells, the kinase activities of all cyclin/cdk complexes were reduced, while p27 levels were increased, leading to a concomitant delay in cell cycle entry.
242
Mad1 belongs to a family of small basic helix-loophelix/leucine zipper-containing transcription repressor proteins which includes Mad1, Mxi, 243 Mad3 and Mad4. 244 All four proteins can dimerise to the same Max protein as c-Myc and compete for binding to the same E-box sequences as cMyc/Max heterodimers. Mad1 had been shown to counteract c-Myc activity and inhibit cell proliferation through its transcriptional repressor activity. 245, 246 This lies in its N-terminal mSin3 binding domain (SID) 245, 247 which recruits HD proteins via binding of mSin3. 246, 248 Expression of mad1 and mxi in hematopoietic cell lines has been reported, [249] [250] [251] whereas mad3 and mad4 seem to be more restricted to epithelial and neural tissues. 244 mad1 was shown to be induced during differentiation of several hematopoietic lineages in vitro [249] [250] [251] and in vivo. 252 Indeed, the differentiation of many cell types is associated with opposite regulation of c-myc (downregulation) and mad1 (up-regulation). That Mad1 may play an important role in the differentiation of myeloid lineages is further supported by data from mad1 knockout mice that exhibited a delayed cell cycle exit of the granulocytic lineage. 253 
Other proteins
Apart from those described above, a number of other transcription factors appear to play a role in granulocytic cells, but these will not be discussed in detail here. Briefly, these include: CDP: The ubiquitous CCAAT displacement protein (CDP) is a negative regulator of a subset of genes which are expressed specifically in more mature granulocytes, including those encoding gp91-phox and lactoferrin.
254-256
Sp1:
Another widely expressed factor, Sp1 is present at particularly high levels in maturing granulocytes and has been implicated in the regulation of several myeloid genes.
14 MZF-1: A zincfinger protein expressed specifically in early myeloid cells, MZF-1 is required for the formation of myeloid colony-forming units. 257 Its enforced expression in a myelomonocytic cell line delayed differentiation and augmented survival. 258 Id proteins: In hematopoietic cells, the inhibitory helix-loophelix proteins Id1 and Id2 are expressed reciprocally during growth and differentiation, with Id2 expression observed to increase as cells mature. 259, 260 Id protein levels decrease early when 32D cl3 cells are exposed to G-CSF, with enforced expression of Id in these cells leading to apoptosis, rather that differentiation, in response to G-CSF. 261 PLZF: The zinc-finger transcription factor PLZF is expressed in immature but not more mature hematopoietic cells. Expression of exogenous PLZF in 32D cl3 myeloid cells slowed their proliferation in IL-3 and inhibited their differentiation in G-CSF. 262 The inhibition of proliferation may have resulted from direct repression of cyclin A gene transcription. model is the concept that transcription factors rather than cytokine receptor signals are the key determinants of lineage commitment. Consistent with this idea, mice lacking G-CSF, the G-CSF receptor, or G-CSF and GM-CSF have at most a two-fold reduction in immature granulocytic precursors and bone marrow neutrophils, 264, 265 whereas those lacking C/EBP␣ or PU.1, for example, show a much greater impairment in granulocyte production. 36, 64, 65 Furthermore, introduction of the G-CSF-R into PU.1-deficient bone marrow cells failed to restore terminal granulocytic differentiation of these cells. 69 The helix-loop-helix transcription factor SCL has been portrayed as the master regulator of hematopoiesis, being absolutely required for generation of a pluripotent stem cell. 266 Subsequent development of pluripotent hematopoietic stem cells requires CBF, c-Myb and GATA-2. The recent observation that GATA-2 can bias murine marrow cells and FDCP-mix cells toward granulocytic differentiation raises the possibility that GATA-2 regulates C/EBP␣ levels. 267 Induction of bipotent lymphoid progenitors requires Ikaros and PU.1. GATA-3 is required for T lymphoid development, while both PU.1 and Pax-5 contribute to B lymphoid development. GATA-1 in combination with C/EBP␣ induces the eosinophil lineage while, in the absence of C/EBP␣, GATA-1 induces the erythroid/megakaryocyte lineages. 38 GATA-1 in combination with Friend of GATA (FOG) and NF-E2 subsequently facilitates megakaryocytic differentiation, while GATA-1 in combination with erythroid Krü ppel-like factor (EKLF) facilitates erythroid development. Finally, PU.1 and C/EBP␣ are important for myeloid development. In this model, C/EBP␣ induces the granulocytic/monocytic lineages, with induction of PU.1 to high levels. This model of hematopoiesis takes account of the finding that C/EBP␣ activates PU.1 gene expression 35 thereby placing C/EBP␣ upstream of PU.1 in myeloid development -with both cooperating in granulocytic differentiation, but with PU.1 being more important in monocytic differentiation. A question remains open in this modelnamely, what determines whether a bipotential G/M progenitor commits to the granulocytic or monocytic lineage? Perhaps this choice is governed by C/EBP levels.
Transcription factor cooperativity in granulopoiesis
While no single transcription factor is expressed only in early myeloid cells (monocyte and granulocyte precursors), the combination of C/EBP␣ with PU.1, CBF and c-Myb is unique to these lineages. Indeed, it appears that it is the cooperation between these factors -together and with other factorswhich is the major driving force in mediating granulopoiesis. C/EBP␤ and c-Myb cooperate to activate the endogenous mim-1 gene in avian cells.
1 C/EBP␣, c-Myb and PU.1 cooperate to activate the murine neutrophil elastase (NE) promoter, and probably cooperate to activate the highly homologous proteinase-3 and azurocidin genes as well, 3, 9 while other C/EBPs, such as C/EBP␤ and C/EBP␦, and other Ets factors, such as GABP and Ets-2, can also cooperate with c-Myb to activate the NE promoter. 268 In addition, the myeloperoxidase (MPO) gene contains two enhancers, a proximal enhancer regulated synergistically by CBF and c-Myb and a distal enhancer activated by PU.1 and C/EBP␣. 11, 89 Importantly for understanding the hierarchy of granulopoietic inducers, both the G-CSF receptor and GM-CSF receptor promoters are regulated by PU.1 and C/EBP␣, 7, 12 and the M-CSF receptor promoter is activated synergistically by C/EBP␣, CBF and PU.1. 4, 10, 90 Transcription inhibitors also contribute to control myeloid gene expression and lineage determination. For example, GATA-1 interacts with PU.1 and interferes with its activation of myeloid genes in erythroid cells. 269, 270 MafB inhibits Ets-1-mediated activation of erythroid genes in myeloid cells, and a related bZIP factor, c-Maf, inhibits Ets-1 and c-Myb activation of the CD13 gene in early myeloid cells which have not yet reached the stage of differentiation at which CD13 expression becomes evident. 271, 272 Inhibition of c-Myb activities is not the only functionally important activity of c-Maf, as c-Maf overexpression directed both the HL-60 and U937 myeloblastic leukemia cell lines to differentiate to monocytes, whereas a dominant-negative c-Myb did not. 273 The transcription factors described above can also influence each other's expression. For example, C/EBP␣-ER rapidly induces PU.1 mRNA levels, even in the presence of cycloheximide in both 32D cl3 myeloid cells and Ba/F3 B lymphoid cells, 35 suggesting that C/EBP␣ acts directly on the PU.1 promoter. In addition, both C/EBP␣ and PU.1 can directly autoactivate their own promoters. [274] [275] [276] Furthermore, Myb regulates the expression of c-Myc, 277 and co-operates with GATA-1 to enhance WT-1 expression.
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Cytokine receptor signals and granulopoiesis
Cytokine receptors expressed in cells of the granulocytic lineage
The production of granulocytic cells is also regulated by a network of hematopoietic growth factors and cytokines. One of these, granulocyte colony-stimulating factor (G-CSF), is a major regulator of neutrophilic granulocyte production, and augments the proliferation, survival, maturation and functional activation of cells of this lineage. 264, 265 The actions of G-CSF are mediated through its interaction with a specific cell-surface receptor, the G-CSF-R, which forms homo-oligomeric complexes upon ligand binding. 279 Typical of other members of the hematopoietin receptor superfamily, the G-CSF-R has no intrinsic tyrosine kinase activity but activates cytoplasmic tyrosine kinases. 279, 280 In addition, the cytokines IL-3 and GM-CSF also play important roles in granulocytic cells through signals from their specific receptors, which have been reviewed recently.
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G-CSF-R signaling
The G-CSF-R is an 813 amino acid membrane protein, including a 188 amino acid cytoplasmic segment which is diagrammed in Figure 3 . The cytoplasmic region of the G-CSF-R can be subdivided into a membrane-proximal domain, which contains two conserved sequences known as box 1 and box 2, and a membrane-distal domain, which contains a less-conserved box 3 sequence. 279 In myeloid cells, the membraneproximal domain is essential for mitogenic signaling, while the membrane-distal domain is essential for the transduction of differentiation signals. 223, [283] [284] [285] In addition, there are four tyrosine (Y) residues in the cytoplasmic region of the G-CSF-R, at positions 704, 729, 744 and 764 of the human receptor, three of which lie in the membrane-distal domain. 286 Ligation of the G-CSF-R results in the rapid phosphorylation of these four tyrosines, 287, 288 which create binding sites for signaling molecules. Some signaling pathways emanating from the different tyrosines of the G-CSF-R have been identified. For example, we and others have shown that Y704 and Y744, and to a lesser extent Y729, of the G-CSF-R are involved in the recruitment and activation of Stat3, 220, 222, 228, 289, 290 while SHP2/Grb2 complexes dock at Y704 and Y764. 228 In addition, Y764 is necessary for the formation of Shc/Grb2/p140 and Grb2/p90 complexes, as well as the activation of p21 ras . 228, 234, 291 Jak2 and/or other Jak kinases bind to the membrane proximal segment between box 1 and box 2 -this binding is dependent upon the integrity of tryptophan 650 (W650).
292 Jak2 activates other proteins, including Stat1, Stat5 and c-Rel. 223, 293, 294 The G-CSF-R also activates the src-kinases Lyn and Hck, [295] [296] [297] the Syk kinase, 295, 296 as well as phosphoinositol 3′-kinase (PI3K), which in turn activates PKB/Akt. 298 Interestingly, mice lacking SHIP, a phosphatase which hydrolyzes the product of PI3K have elevated PKB/Akt kinase activity and myeloid hyperplasia. 299 To better define the role of signaling pathways from the G-CSF-R, we recently examined the ability of a series of tyrosine mutants to transduce biological signals in response to G-CSF in maturation-competent myeloid 32D cells. 228 These cells can closely recapitulate many of the normal responses to G-CSF, including proliferation, survival, and, importantly, terminal differentiation into mature neutrophils, 285 and therefore provide an appropriate cellular context to assess the physiological relevance of these signals. This analysis revealed that multiple tyrosines contribute to proliferation, differentiation and survival signaling from the human G-CSF-R. Analysis of signaling pathways downstream from these tyrosines suggest a positive role for Stat3 activation in both differentiation and survival, 228 in agreement with data obtained using dominantnegative Stat3 in myeloid cells. 227, 300, 301 In contrast, SHP-2, Grb2 and Shc appear to be important for proliferation, 228 suggesting an important role for p21 ras , which lies downstream. 234 Consistent with this conclusion, a dominant-negative Ras, RasN17, inhibited the proliferation, but not the differentiation, of 32D cl3 cells. 302 Finally, we also showed that an as yet illdefined tyrosine-independent 'differentiation domain' in the membrane-distal region of the G-CSF-R appears necessary, although not sufficient, for mediating neutrophilic differentiation in 32D cells. 228 
Role of G-CSF-R signals in granulopoiesis
Mice lacking G-CSF, the G-CSF-R, or G-CSF in combination with GM-CSF have at most a two-fold reduction in immature Signaling from the G-CSF-R. Schematic representation of the G-CSF-R cytoplasmic domain with known receptor tyrosine-dependent and independent signaling pathways indicated. The exact mechanism of activation for Lyn, Hck, Syk and PI3K remain unknown. Please see text for further discussion. granulocytic precursors and marrow neutrophils. 264, 265 Peripheral neutrophils are reduced approximately five-fold, perhaps due in part to a defect in their release from the marrow. 303 Redundant signals from other cytokine receptors may compensate for the lack of G-CSF-R signals in these mice. Additional evidence for a direct role of G-CSF-R signals in granulopoiesis comes from patients with severe congenital neutropenia (SCN). Their marrow shows an arrest at the promyelocyte or myelocyte stages of neutrophil development. Truncations of the G-CSF-R cytoplasmic domain have been detected in approximately 25% of SCN patients. 283, 304 Mice carrying such a mutation are also neutropenic, although not as severely as human patients with SCN. 305 In addition, we have recently identified a mutation in the extracellular domain of the G-CSF-R in another SCN patient. 230 Loss of signals from the M-CSF receptor in mice lacking M-CSF can be compensated for by transgenic expression of an anti-apoptotic protein, bcl-2, in monocytic cells. 306 Similarly, transgenic expression of bcl-2 in T cells rescues T lymphocyte development in mice lacking the IL-7 receptor. 307 However, bcl-2 does not rescue erythroid development in mice lacking the erythropoietin receptor. 308 Similarly, bcl-2 did not enable 32D cl3 cells to express MPO or Cathepsin G in the absence of G-CSF, although nuclear morphologic changes did occur. 309 Thus, some receptors, including the G-CSF-R, probably provide more than merely survival signals to enable lineage development.
Transcriptional collaboration with cytokine receptor signals
It is presumed that the bulk of signals emanating from cytokine receptors ultimately converge in the nucleus to affect myeloid gene transcription, largely via stimulation, suppression and collaboration with a range of transcription factors. Cytokine receptors, including the G-CSF-R, activate c-Jun via the JNK pathway. 310 c-Jun and PU.1 physically interact via their DNAbinding domains and have been shown to cooperate to activate transcription in U937 cells via a PU.1-binding site. 311, 312 c-Jun and PU.1 also cooperate to activate the macrosialin gene in monocytic cells via neighboring AP-1 and PU.1 DNAbinding sites. 313 In addition, the receptors for G-CSF, GM-CSF and IL-3 all activate Ras and components of the MAPK pathway. 234, 282 MAPKs are known to phosphorylate a number of transcription factors, including PU.1 53 and C/EBP␤. 314 In addition, Ras and C/EBP␣ cooperatively activate the G-CSF-R promoter in 293T cells, an adherent epithelial cell line. 315 This activation is dependent upon phosphorylation of serine 248 by protein kinase C (PKC). Whether Ras activation leads to PKC-dependent C/EBP␣ phosphorylation in hematopoietic cells is unknown. In addition, Ras activation is required for cMyb to induce GBX2, a homeodomain protein, in avian myeloid cells. 316 The c-Myb interacting protein p100 can be activated by the Pim-1 kinase, which itself is activated by Ras, potentially providing the link to explain the involvement of Ras in modulating c-Myb activity. 317 
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Typical of other cytokine receptors, the G-CSF-R induces cMyc, 234 which itself induces important cell cycle genes, as well as indirectly sequestering p27 to increase cyclinE/CDK2 activity. 239, 240 In addition, Stat5 is activated by the G-CSF-R, GM-CSF-R and IL-3-R 219,223 which can induce cyclin gene expression 218, 318 to further promote proliferation in the early phases of granulocytic differentiation. In the later phases of G-CSF-mediated granulocytic differentiation, Stat5 activation decreases, while Stat3 remains high. 223 This leads to increased expression of p27 thereby promoting growth arrest. 301 Consistent with a role for Stat3 in delayed growth arrest, dominantnegative Stat3 prevents terminal granulopoiesis and enables the continuous proliferation of LGM-1(G-CSF-R) and 32D cl3 cells in the presence of G-CSF. 227, 301 Mad1 is also induced during G-CSF-mediated granulopoiesis which can inhibit Myc activities (AS-B, D van Leeuwen, Y van Aesch, IPT, unpublished data). Such a synergistic effect of Mad1 and p27 in achieving growth arrest in granulocytic cells has also been reported using murine knockout models. 253 Potentially related to these observations, C/EBP␣, like G-CSF, induces a delayed G1/S cell cycle arrest in 32D cl3 cells. 35 Induction of cell cycle arrest was independent of differentiation, as it occurred also in the presence of p210 Bcr-Abl , which prevented all aspects of C/EBP␣-induced granulopoiesis except PU.1 induction. C/EBP␣ also induces cell cycle arrest in adipocytes and hepatocytes, perhaps via direct interaction with p107, a homologue of Rb. [319] [320] [321] Induction of p27 Kip1 was also evident in 32D cl3 cells expressing C/EBP␣-ER. 35 Therefore, we would speculate that Stat3 activation of the p27 promoter 301 occurs in cooperation with a C/EBP or another transcription factor active in maturing granulocytes. Either induction of p27 or direct inactivation of an Rb or p107 complex could account for the recent finding that C/EBP␣ inhibits c-Myc gene transcription in a myeloid cell line via an E2F-binding site in its promoter. 322 
C/EBP␣:G-CSF-R interactions -a model of granulopoiesis
We have recently obtained evidence that G-CSF-R signals, although redundant with signals of other cytokine receptors, can cooperate with exogenous C/EBP␣ to activate the endogenous MPO and NE genes in a lymphoid cell line. 323 In addition, the integrity of both the C/EBP␣-and PU.1-binding sites is known to be required for induction of the neutrophil elastase promoter by G-CSF receptor signals, 3, 9 while NF-Y may play a role in G-CSF-dependent MPO transcription, via its binding site in the MPO promoter. 324 Perhaps G-CSF-R signals contribute to C/EBP␣ gene induction in immature myeloid cells, as C/EBP␣ protein and RNA levels and transcription initiation rate increase rapidly when 32D cl3 cells are transferred from IL-3 to G-CSF 31 (L Scott and ADF, unpublished). C/EBP␣ -in co-operation with PU.1 -in turn activates the G-CSF-R promoter, and perhaps the IL-6 gene, generating a positive feedback loop which fixes the commitment of myeloid progenitors. 12, 325 Figure 4 presents a model of granulopoiesis beginning with G-CSF receptor signals. While these signals may be redundant with those emanating from other receptors with respect to the regulation of early granulopoiesis, they may be required specifically for late granulopoiesis, 265 where they cooperate to elicit cell cycle arrest and induce specific genes, just as signals from the TPO receptor are required for terminal thrombopoiesis. 326, 327 Alternatively, the major function of G-CSF-
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Figure 4
Control of granulopoiesis by transcription factors and G-CSF-R signals. G-CSF-R signals may induce C/EBP␣, while C/EBP␣ in turn can induce the G-CSF-R. C/EBP␣ also induces PU.1 and both factors, in co-operation with CBF and c-Myb and loss of c-Maf inhibition, induce early markers of granulopoiesis. C/EBP␣ and Stat3 contribute to G1/S cell cycle arrest, and hypophosphorylated Rb then cooperates with late acting transcription factors and loss of CDP activity to induce terminal granulopoiesis. In addition, the G-CSF-R can exert a positive effect on cell cycle progression via Stat5 and c-Myc, the latter of which can be counteracted by Mad1 induction. Please see text for further discussion.
R signals may be to provide an enhancement of granulocyte production and survival required, for example, in response to infection when G-CSF levels rise steeply. 264 In this scenario, induction of Myc and activation of Stat5 could clearly be important for inducing proliferation.
Conclusion
Studies of gene regulation in immature myeloid cells have pinpointed a group of transcription factors which coordinate early granulopoiesis. Similar investigations of genes transcribed specifically during late granulopoiesis are beginning to uncover factors which control this phase of differentiation. Additional transcription factors have also been identified based on their lineage-restricted expression pattern or their role in leukemogenesis as being important for regulating granulopoiesis. A key goal for future investigation is to organize these various factors and signals emanating from cytokine receptors into pathways which direct each step of maturation, from the pluripotent hematopoietic stem cell, to a committed myeloid progenitor, to myeloid precursors, and ultimately to mature granulocytes. This goal will be facilitated by identifying the primary genetic targets of each factor, the phosphorylation sites which regulate their activities, and the coactivators which facilitate their function. Finally, thorough characterization of mice with lineage-and stage-specific perturbations in the expression of one or more regulatory factor will also assist in the development of a molecular model of granulopoiesis.
